ADAR1 Capital Management »

Hookipa Pharma Inc equity shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Hookipa Pharma Inc equity shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Hookipa Pharma Inc equity

Tip: Access up to 7 years of quarterly data

All positions including Hookipa Pharma Inc equity held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hookipa Pharma Inc equity by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $36k 50k 0.71

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Hookipa Pharma Inc equity

EcoR1 Capital
Vanguard Group
Knoll Capital Management
Morgan Stanley
State Street Corporation
BlackRock
Two Sigma Investments
Two Sigma Advisers
Tower Research Capital
Two Sigma Securities
Qube Research & Technologies

View all funds holding Hookipa Pharma Inc equity